does nourish prescribe glp 1 Raises $100M to Expand AI-Driven Metabolic Care Platform Amid GLP-1 Boom GLP-1 is everywhere right now

No exceder la cantidad diaria recomendada

First approved dual GIP/ GLP-1 receptor agonist tirzepatide (Mounjaro) added to guidelines Stimulates incretin effect, promoting insulin secretion and glucose clearance after meals Rated very high efficacy for A1C% and weight reduction Cardiorenal benefit currently under investigation Subcutaneous injection administered once weekly Gastrointestinal adverse effects may occur initially and decrease over time See Section 9

doi: 10.1080/09513590.2021.1878138 167 SukanBAkdevelioluYSukanVN

To generate both scExe4 and Cas9 plasmid-loaded LNPs, the molecular ratio of DLin-MC3-DMA/Cholesterol/DSPC/PEG2000-DMG was 50/38.5/10/1.5, following a previously established protocol 23,24,25